Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRC041266 in Diabetic Patients with Chronic Stable Heart Failure
NCT04507347Phase 3Withdrawn
- Sponsor
- Torrent Pharmaceuticals Limited
- Start
- Jun 2021
- Primary completion
- Jun 2024
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of TRC041266 in chronic heart failure (CHF), sponsored by Torrent Pharmaceuticals Limited. Planned start Jun 2021; status: withdrawn.
02
Drugs
TRC041266
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on NCT04507347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04507347.